The chirality selectivity in the uptake of platinum (II) complexes with 1,2-cyclohexanediamine isomers as carrier ligand by human erythrocytes

BioMetals

Volumn 10, Issue 1, 1997, Pages 37-43

  Zou, Juan ^a   Yang, Xiao Gai ^b   Li, Rong Chang ^b   Lu, Jing Fen ^b   Wang, Kui ^b  

^a NANJING UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

1,2 cyclohexanediamine; Chirality; Human erythrocyte; Platinum complexes; Uptake

Indexed keywords

CHLORIDE; CISPLATIN DERIVATIVE; DRUG CARRIER; OXALIC ACID; PLATINUM 1,2 DIAMINOCYCLOHEXANE; PLATINUM COMPLEX; SQUARIC ACID;

ARTICLE; CHIRALITY; CONTROLLED STUDY; DRUG UPTAKE; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; HUMAN; HUMAN CELL; ISOMER; KINETICS;

CELL MEMBRANE PERMEABILITY; CYCLOHEXYLAMINES; DRUG CARRIERS; ERYTHROCYTES; HUMANS; MEMBRANE PROTEINS; MOLECULAR CONFORMATION; ORGANOPLATINUM COMPOUNDS; PROTEIN CONFORMATION;

EID: 0031027821     PISSN: 09660844     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018314719904     Document Type: Article

References (17)

1. Dodge JT, Mitchell C, Hanahan DJ. 1963 The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Arch Biochem Biophys 100, 119-130.
2. Ellman GL. 1959 Tissue sulfhydryl groups. Arch Biochem Biophys 82, 70-77.
3. Gately DP, Howell SB. 1993 Cellular accumulation of the anticancer agent cisplatin: a review. Br J Cancer 67, 1171-1176.
4. Inagaki K, Kidani Y. 1986 Difference in binding of (1,2-cyclohexanediamine) platinum(II) isomers with d(GpG). Inorg Chem 25, 1-3.
5. 1H NMR spectroscopy. Inorg Chem 29, 4496-4500.
6. Keith AD, Bulfield G, Snipes W. 1970 Spin-labeled neurospora mitochondria. Biophys J 10, 618-629.
7. Kidani Y, Noji M. 1991 Developmental approach to prepare new types of antitumor platinum complexes with dual function. In: Howell SB, ed. Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy. New York: Plenum Press; 127-137.
8. Kornberg RD, McConnell HM. 1971 Inside-outside transitions of phospholipids in vesicle membranes. Biochemistry 10, 1111-1120.
9. Lammel B, Maier G. 1980 A spin labeling study of the effects of inorganic ions and pH on the conformation of spectrin. Biochim Biophys Acta 622, 245-258.
10. Lu JF, An PD, Ma YL, et al. 1995a Study of permeability of cis-spin labeled platinum complexes through human erythrocyte membrane. Acta Biophysica Sinica 11, 195-200.
11. Lu JF, Wang K, Sun XZ, et al. 1995b Effects of cisplatin and its analogues on the permeability of human erythrocyte membrane. Metal-Based Drugs 2, 73-80.
12. Reile H, Bernhardt G, Koch M, et al. 1992 Chemosensitivity of human MCF-7 breast cancer cells to diastereoisomeric diaqua (1,2-diphenylethylenediamine) platinum (II) sulfates and specific platinum accumulation. Cancer Chemother Pharmacol 30, 113-122.
13. Sandberg HE, Bryant RG, Piette LH. 1969 Location of sulfhydryl groups in erythrocyte membranes with magnetic resonance spin probes. Arch Biochem Biophys 133, 144-152.
14. Speer RJ, Hall LM, Stewart DP, et al. 1978 Antitumor activity of platinum complexes of 1,2-diaminocyclohexane isomers. J Clin Hematol Oncol 8, 44-50.
15. Wang K, Lu JF, Li RC. 1996 Events happening when cisplatin molecules encounter the cell. Coord Chem Rev 151, 53-88.
16. Zhang WM, Li LZ, Li RC, et al. 1993 The kinetic studies of across-erythrocyte membrane transport of platinum (II) complexes. Chemical J Chinese Univ 14, 1351-1353.
17. Zou J. 1995 Ph.D. thesis, Nanjing University, China.